Correspondence 0001640334-26-000905 from ARTELO BIOSCIENCES, INC. (ARTL)
ARTELO BIOSCIENCES, INC.
Date: May 15, 2026 · CIK: 0001621221 · Accession: 0001640334-26-000905
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295537
Letter
artl_corresp.htm Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach, CA 92075 May 15, 2026 U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC. 20549 Attn: Doris Stacey Gama Re: Artelo Biosciences, Inc. Registration Statement on Form S-3 (File No. 333-295537) Ladies and Gentlemen, Pursuant to Rule 461 under the Securities Act of 1933, as amended, Artelo Biosciences, Inc. hereby respectfully requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) and declare such Registration Statement effective at 5:00 p.m. (Eastern Time) on Tuesday, May 19, 2026, or as soon thereafter as practicable. It would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform Louis A. Bevilacqua of Bevilacqua PLLC at (202) 869-0888, ext. 100. Respectfully, Artelo Biosciences, Inc. By: /s/ Gregory D. Gorgas Gregory D. Gorgas Chief Executive Officer cc: Louis A. Bevilacqua, Esq.
Show Raw Text
CORRESP 1 filename1.htm artl_corresp.htm Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach, CA 92075 May 15, 2026 U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC. 20549 Attn: Doris Stacey Gama Re: Artelo Biosciences, Inc. Registration Statement on Form S-3 (File No. 333-295537) Ladies and Gentlemen, Pursuant to Rule 461 under the Securities Act of 1933, as amended, Artelo Biosciences, Inc. hereby respectfully requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) and declare such Registration Statement effective at 5:00 p.m. (Eastern Time) on Tuesday, May 19, 2026, or as soon thereafter as practicable. It would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform Louis A. Bevilacqua of Bevilacqua PLLC at (202) 869-0888, ext. 100. Respectfully, Artelo Biosciences, Inc. By: /s/ Gregory D. Gorgas Gregory D. Gorgas Chief Executive Officer cc: Louis A. Bevilacqua, Esq.